When Did Eylea Launch?
Fda Approves Eylea for Wet Age-Related Macular Degeneration. November 18, 2011. Is Aflibercept Fda Approved? Regeneron Pharmaceuticals, Inc. (Nasdaq: Regn)...
FDA approves Eylea for wet age-related macular degeneration. November 18, 2011.
Is aflibercept FDA approved?
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration ( FDA ) has approved EYLEA® (aflibercept) Injection to treat all stages of diabetic retinopathy (DR), and thereby reduce the risk of blindness.
Must Read
What company makes Eylea?
EYLEA® (aflibercept) Injection by Regeneron.